Nanchong Gewosai Electronic Commerce Co., Ltd. – Trademark Portfolio

Entity Type: 99

Nanchong Gewosai Electronic Commerce Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include GROZAV. The owner is based in Nanchong,Sichuan.

No. 261, 1st Floor, Liulin Road

Nanchong,Sichuan 637000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GROZAV
GROZAV
Registered 2022

Trademark Classifications

Nanchong Gewosai Electronic Commerce Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Nanchong Gewosai Electronic Commerce Co., Ltd. have?

Nanchong Gewosai Electronic Commerce Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Nanchong Gewosai Electronic Commerce Co., Ltd. file in?

Nanchong Gewosai Electronic Commerce Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Nanchong Gewosai Electronic Commerce Co., Ltd.'s most well-known trademarks?

Nanchong Gewosai Electronic Commerce Co., Ltd.'s registered trademark portfolio includes well-known marks such as GROZAV. These are among 1 currently registered trademark in the portfolio.

What is Nanchong Gewosai Electronic Commerce Co., Ltd.'s trademark registration success rate?

Nanchong Gewosai Electronic Commerce Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.